NPC1L1: from drug target to physiological sterol transporter

Author： L Pollex Rebecca   A Hegele Robert  

Publisher： Future Medicine

ISSN： 1746-0875

Source： Future Lipidology, Vol.1, Iss.3, 2006-06, pp. : 247-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dissecting NPC1L1-mediated cholesterol absorption

By Qi Wei   Song Bao-Liang  

Future Lipidology, Vol. 3, Iss. 5, 2008-10 ,pp. : 481-484

Future Medicine

Access to resources Recommend Favorite

Du nouveau dans l’absorption intestinale du cholestérol : NPC1-L1

By Lambert Gilles   Chetiveaux Maud   Sénard Gaylord   Drui Delphine   Krempf Michel  

Médecine/sciences, Vol. 20, Iss. 6-7, 2013-05 ,pp. : 636-638

Edp Sciences

Access to resources Recommend Favorite

Upregulation of Caveolin‐1 correlate with Akt expression and poor prognosis in NPC patients

By  

THE LARYNGOSCOPE, Vol. 125, Iss. 7, 2015-07 ,pp. : E231-E238

John Wiley & Sons Inc

Access to resources Recommend Favorite

L‐type amino acid transporter‐1 and CD98 expression in bone and soft tissue tumors

By  

PATHOLOGY INTERNATIONAL, Vol. 65, Iss. 9, 2015-09 ,pp. : 460-467

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cholesterol metabolism and noncholesterol sterol distribution in lipoproteins of Type 1 diabetes

By Tomkin Gerald H  

Future Lipidology, Vol. 3, Iss. 1, 2008-02 ,pp. : 17-21

Future Medicine

Access to resources Recommend Favorite